Sign in
CompletedNo phase

Transcranial Direct Current Stimulation (tDCS) in Human Subjects With PTSD Receiving an Exposure-based, Behavioral Therapy

Key facts

Who runs it
The University of Texas Health Science Center at San Antonio
Where
San Antonio, United StatesSee the site
Trial code
Status
Completed
People taking part
25 people enrolled
Started
9 Jan 2023
Ended
25 Apr 2024
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Soterix 1x1 tDCS mini CT
  • Sham Soterix 1x1 tDCS Mini CT
  • Written Exposure Therapy (WET)
Record updated
29 May 2025

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Individuals between the ages of 18 and 65 years old at time of screening
  • PTSD diagnosis as assessed by the Clinician-Administered Posttraumatic Stress Scale (CAPS-5)
  • Able to write, read, and speak English

Who cannot take part

  • Change in anticonvulsive or benzodiazepine medication regimen in the past month
  • History of adverse effects to previous tDCS or other brain stimulation technique
  • Concurrent engagement in another brain simulation technique or trauma-related psychotherapy for PTSD
  • History of epilepsy or seizures
  • History of significant intracranial pathology (e.g., severe traumatic brain injury) or neurological disorder (e.g., Stroke, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Alzheimer's, Dementia, Parkinson's, and/or Huntington's)
  • History of skin condition (e.g., eczema, psoriasis) where electrodes will be applied
  • Electronic implants in the body that could be susceptible to electrical current (e.g., cardiac pacemaker, cochlear implants, medical pump)
  • Current moderate or severe substance use disorder
  • Suicidality and/or psychiatric risk requiring immediate intervention or a higher level of care than can be provided by the study treatment
  • Metallic objects other than dental appliances/fillings near the site of stimulation
  • Current manic episode or psychotic symptoms requiring immediate stabilization or hospitalization (as determined by clinical judgement)
  • Currently pregnant or breastfeeding

Where in United States

  • The University of Texas Health Science Center at San AntonioSan Antonio, United States

About the trial

What the trial wants to find out

The primary objective of this study is to evaluate the safety, feasibility, and psychological and physiological treatment benefits of transcranial direct current stimulation (tDCS), a noninvasive brain stimulation technique, when delivered in combination with Written Exposure Therapy (WET), for posttraumatic stress disorder posttraumatic stress disorder (PTSD).

The 2 groups in the trial

  • tDCS plus WETTreatment being tested

    Subjects will receive transcranial direct current stimulation (tDCS) plus written exposure therapy (WET)

    Treatment: Soterix 1x1 tDCS mini CT and Written Exposure Therapy (WET)

  • Sham plus WETSham treatment, for comparison

    Subjects will receive sham transcranial direct current stimulation (tDCS) treatment plus written exposure therapy (WET)

    Treatment: Sham Soterix 1x1 tDCS Mini CT and Written Exposure Therapy (WET)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Safety, Feasibility, and Benefits of Transcranial Direct Current Stimulation (tDCS) in Human Subjects With Posttraumatic Stress Disorder (PTSD) Receiving an Exposure-based, Behavioral Therapy
Record updated
29 May 2025